Cancer experts and scientists "Meet the Greek" – Fred Hutch Cancer Center's Dr. Petros Grivas – to discuss their work. This biweekly podcast explores the latest developments in cancer care and research. Dr. Grivas emphasizes the importance of learning from colleagues, engaging with patients, and fostering community partnerships. The podcast will feature diverse guests and cover a range of topics, including innovative treatments, clinical trials, and educational initiatives in oncology.
Oncology Insights with Petros Grivas
Claim This Podcastby Petros Grivas
5.0(5 reviews)
17 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇺🇸
Podcast Overview
Cancer experts and scientists "Meet the Greek" – Fred Hutch Cancer Center's Dr. Petros Grivas – to discuss their work. This biweekly podcast explores the latest developments in cancer care and research. Dr. Grivas emphasizes the importance of learning from colleagues, engaging with patients, and fostering community partnerships. The podcast will feature diverse guests and cover a range of topics, including innovative treatments, clinical trials, and educational initiatives in oncology.
Language
🇺🇲
Publishing Since
11/5/2025
1 verified contact email on file for Oncology Insights with Petros Grivas
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
June 30, 2026
Inside Sarcoma Care: New Therapies, Clinical Trials & Team-Based Treatment
<p>In this episode of the Oncology Insights Podcast, host Petros Grivas MD, PhD, FASCO, sits down with Lara Davis, MD, head of the Sarcoma Program at Fred Hutch Cancer Center, to discuss the latest treatment advances for sarcomas, ongoing clinical trials, multidisciplinary care and the importance of working with community oncologists to improve patient outcomes.</p> <p><strong>Timestamps:</strong></p> <ul> <li>00:07 - Introduction to Dr. Lara Davis and her role at Fred Hutch</li> <li>05:58 - Overview of the diverse sarcoma types and diagnostic challenges</li> <li>06:27 - The rarity of individual sarcoma subtypes despite their collective importance</li> <li>08:41 - The value of multidisciplinary teams in sarcoma care</li> <li>11:33 - Germline mutations associated with sarcoma risk, including Li-Fraumeni syndrome</li> <li>13:27 - Outpatient vs inpatient chemotherapy management</li> <li>16:56 - Exciting clinical trials at Fred Hutch, including the ASCO sarcoma plenary </li> <li>17:54 - Innovative trial combining CDK4/6 inhibitors with radiation for liposarcoma</li> <li>21:36 - Collaboration with community practices to ensure patient access</li> <li>25:57 - Future vision: biomarkers, targeted therapies, and advancing sarcoma care</li> <li>28:48 - The potential of immunotherapy and CAR T-cell approaches in sarcoma</li> <li>32:07 - Closing remarks and future prospects for sarcoma research</li> </ul> <p><strong>Resources & Links:</strong></p> <ul> <li>Dr. Lara Davis: <a href= "https://www.fredhutch.org/en/provider-directory/lara-davis.html">https://www.fredhutch.org/en/provider-directory/lara-davis.html</a></li> <li>Dr. Petros Grivas: <a href= "https://www.fredhutch.org/en/provider-directory/petros-grivas.html"> https://www.fredhutch.org/en/provider-directory/petros-grivas.html</a></li> </ul>
June 16, 2026
The Evolution of Stem Cell Transplantation – Insights from Dr. Marco Mielcarek
<p data-pm-slice="1 1 []">Join us as we explore the incredible advancements in stem cell transplantation with Marco Mielcarek, MD, PhD, director of the Blood and Marrow Transplantation Program at Fred Hutch. Discover the journey from the early days of transplantation to cutting-edge techniques that are transforming patient outcomes worldwide.</p> <p><strong>In this episode, you will learn about:</strong></p> <ol class="ProsemirrorEditor-list"> <li class="ProsemirrorEditor-listItem" data-list-indent="1" data-list-type="bulleted"> <p>Dr. Mielcarek's personal journey from Berlin to Seattle and his long-standing contributions since 1994</p> </li> <li class="ProsemirrorEditor-listItem" data-list-indent="1" data-list-type="bulleted"> <p>The historical evolution of the Fred Hutch Cancer Center's infrastructure and comprehensive cancer care services</p> </li> <li class="ProsemirrorEditor-listItem" data-list-indent="1" data-list-type="bulleted"> <p>Key progress in stem cell transplantation, including the role of Nobel laureate Don Thomas</p> </li> <li class="ProsemirrorEditor-listItem" data-list-indent="1" data-list-type="bulleted"> <p>Strategies to manage and reduce graft-versus-host disease (GVHD) over the decades</p> </li> <li class="ProsemirrorEditor-listItem" data-list-indent="1" data-list-type="bulleted"> <p>The impact of post-transplant cyclophosphamide technology in expanding donor pools and reducing complications</p> </li> <li class="ProsemirrorEditor-listItem" data-list-indent="1" data-list-type="bulleted"> <p>How outpatient care models are revolutionizing patient recovery and follow-up after transplantation</p> </li> <li class="ProsemirrorEditor-listItem" data-list-indent="1" data-list-type="bulleted"> <p>The future of transplantation: safer, less toxic regimens and targeted therapies like CAR T-cells</p> </li> <li class="ProsemirrorEditor-listItem" data-list-indent="1" data-list-type="bulleted"> <p>The importance of becoming a donor through the <a class= "ProsemirrorEditor-link" href="https://bethematch.org/">National Marrow Donor Program</a> and how donors help save lives</p> </li> </ol> <p><strong>Timestamps:</strong></p> <p>00:00 - Introduction</p> <p>00:36 - Dr. Mielcarek's story and early career in Berlin</p> <p>01:52 - Transition to Seattle and research focus on bone marrow microenvironment</p> <p>03:10 - Infrastructure evolution at Fred Hutch and historical context of transplantation</p> <p>04:33 - Progress in cancer treatment and transplant outcomes</p> <p>05:34 - Focus on managing toxicity and improving survival rates</p> <p>05:55 - Advancements in GVHD prevention and treatment strategies</p> <p>08:10 - Patient access and logistics of transplantation, including international patients</p> <p>09:53 - The donor selection process and international collaboration</p> <p>12:48 - Coordinating outpatient and inpatient transplant care</p> <p>15:43 - Cutting-edge research: post-transplant cyclophosphamide and its impact</p> <p>19:05 - How to become a donor and expand the donor pool</p> <p>23:38 - Future predictions for transplantation physics and methodology</p> <p>27:58 - Innovative approaches and ongoing studies to improve safety and efficacy</p> <p><strong>Resources & Links:</strong></p> <ol class="ProsemirrorEditor-list"> <li class="ProsemirrorEditor-listItem" data-list-indent="1" data-list-type="bulleted"> <p><a class="ProsemirrorEditor-link" href= "https://www.fredhutch.org/en/provider-directory/marco-mielcarek.html"> Marco Mielcarek</a></p> </li> <li class="ProsemirrorEditor-listItem" data-list-indent="1" data-list-type="bulleted"> <p><a class="ProsemirrorEditor-link" href= "https://www.fredhutch.org/en/provider-directory/petros-grivas.html"> Petros Grivas</a></p> </li> <li class="ProsemirrorEditor-listItem" data-list-indent="1" data-list-type="bulleted"> <p><a class="ProsemirrorEditor-link" href= "https://bethematch.org/">Be The Match - National Marrow Donor Program</a></p> </li> </ol> <p> </p>
June 2, 2026
Exploring Neuro-Oncology Leadership and Innovation with Dr. Vyshak Venur
<p data-pm-slice="1 1 []">Join Dr. Petros Grivas in this episode of the Oncology Insights Podcast as he hosts Dr. Vyshak Venur, a leader in neuro-oncology and Deputy Chief Medical Officer at Fred Hutch. Discover insights into career development, groundbreaking neuro-oncology research and the future of precision medicine in cancer care.</p> <p data-pm-slice="1 1 []"><strong>Main Topics:</strong></p> <ol class="ProsemirrorEditor-list"> <li class="ProsemirrorEditor-listItem" data-list-indent="1" data-list-type="bulleted"> <p>Dr. Vyshak Venur's journey from India to leadership at Fred Hutch</p> </li> <li class="ProsemirrorEditor-listItem" data-list-indent="1" data-list-type="bulleted"> <p>Advances and ongoing clinical trials in neuro-oncology</p> </li> <li class="ProsemirrorEditor-listItem" data-list-indent="1" data-list-type="bulleted"> <p>The importance of multidisciplinary care in neuro-oncology</p> </li> <li class="ProsemirrorEditor-listItem" data-list-indent="1" data-list-type="bulleted"> <p>Use of AI and precision medicine in future cancer treatments</p> </li> <li class="ProsemirrorEditor-listItem" data-list-indent="1" data-list-type="bulleted"> <p>Strategies to improve patient access and community outreach</p> </li> <li class="ProsemirrorEditor-listItem" data-list-indent="1" data-list-type="bulleted"> <p>Mentorship, education, and leadership in oncology</p> </li> <li class="ProsemirrorEditor-listItem" data-list-indent="1" data-list-type="bulleted"> <p>Future trends in neuro-oncology and immunotherapy</p> </li> </ol> <p><strong>Timestamps:</strong></p> <p>00:07 - Introduction to Dr. Vyshak Venur and his role at Fred Hutch</p> <p>01:01 - Vyshak's journey from India, Singapore, Cleveland Clinic to Fred Hutch</p> <p>04:15 - Advances in neuro-oncology with new drug approvals and trials</p> <p>04:49 - Challenges and future opportunities in neuro-oncology</p> <p>06:56 - Multidisciplinary approach to neuro-oncology care at Fred Hutch</p> <p>07:55 - The unique Brain Metastasis Clinic and clinical trials landscape</p> <p>09:04 - Exciting ongoing trials including IDH inhibitors and CAR-T therapy</p> <p>11:04 - Importance of rapid patient access initiatives</p> <p>12:45 - Mentorship, education, and nurturing future oncologists</p> <p>14:20 - Leadership roles and organizational vision, including collaboration with Dr. Shadman and Dr. Purcell</p> <p>16:49 - Engaging community practices and improving communication channels</p> <p>19:39 - Inpatient care teams and innovative therapies like CAR-T</p> <p>21:20 - Future of oncology: AI, big data, and personalized medicine</p> <p>22:43 - Translational research at Fred Hutch and integration of lab and clinical advancements</p> <p>24:07 - The legacy of immunotherapy and future directions</p>
17 total episodes available
Similar Podcasts
Discover related shows you might enjoy
Deep-dive analytics for Oncology Insights with Petros Grivas
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Oncology Insights with Petros Grivas?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.